Intolerant Antibodies
South San Francisco, US · Founded 2024
Founders & leadership
MS
Maryam ShansabExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$1.1MraisedJun 2024 · 4 investors · OtherRule 506(b)
▶$1.1MraisedJun 2024 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Maryam ShansabExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- May 2024
- Incorporated
- Corporation, California, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.